TY - JOUR
T1 - Management of Splanchnic Vein Thrombosis in Patients With Acute Pancreatitis
T2 - An International Survey of Current Practice
AU - Ghazanfar, Mudassar A.
AU - Ke, Lu
AU - Ramsay, George
AU - Smith, Martin
AU - Giovinazzo, Francesco
AU - Mohamed, Moustafa
AU - Pandanaboyana, Sanjay
AU - Huang, Wei
AU - Ahmed, Irfan
AU - Siriwardena, Ajith K.
AU - Windsor, John A.
AU - Bekheit, Mohamed
N1 - The authors declare no conflict of interest.
PY - 2022/10
Y1 - 2022/10
N2 - Objectives: Splanchnic venous thrombosis (SpVT) is a complication of acute pancreatitis (AP). There is scarce literature on the prevalence and treatment of SpVT in AP. The aim of this international survey was to document current approaches to the management of SpVT in patients with AP. Methods: An online survey was designed by a group of international experts in the management of AP. Twenty-eight questions covered the level of experience of the respondents, disease demographics, and management of SpVT. Results: There were 224 respondents from 25 countries. Most respondents (92.4%, n = 207) were from tertiary hospitals and predominantly consultants (attendings, 86.6%, n = 194). More than half of the respondents (57.2%, n = 106) "routinely"prescribed prophylactic anticoagulation for AP. Less than half of the respondents (44.3%, n = 82) "routinely"prescribed therapeutic anticoagulation for SpVT. A clinical trial was considered justified by most respondents (85.4%, n = 157) and 73.2% (n = 134) would be willing to enroll their patients. Conclusions: The approach to anticoagulation in the treatment of patients with SpVT complicating AP was highly variable. Respondents indicate that a position of equipoise exists to justify randomized evaluation.
AB - Objectives: Splanchnic venous thrombosis (SpVT) is a complication of acute pancreatitis (AP). There is scarce literature on the prevalence and treatment of SpVT in AP. The aim of this international survey was to document current approaches to the management of SpVT in patients with AP. Methods: An online survey was designed by a group of international experts in the management of AP. Twenty-eight questions covered the level of experience of the respondents, disease demographics, and management of SpVT. Results: There were 224 respondents from 25 countries. Most respondents (92.4%, n = 207) were from tertiary hospitals and predominantly consultants (attendings, 86.6%, n = 194). More than half of the respondents (57.2%, n = 106) "routinely"prescribed prophylactic anticoagulation for AP. Less than half of the respondents (44.3%, n = 82) "routinely"prescribed therapeutic anticoagulation for SpVT. A clinical trial was considered justified by most respondents (85.4%, n = 157) and 73.2% (n = 134) would be willing to enroll their patients. Conclusions: The approach to anticoagulation in the treatment of patients with SpVT complicating AP was highly variable. Respondents indicate that a position of equipoise exists to justify randomized evaluation.
KW - acute pancreatitis
KW - anticoagulation
KW - splanchnic circulation
KW - thrombosis
UR - https://www.scopus.com/pages/publications/85153414134
U2 - 10.1097/MPA.0000000000002165
DO - 10.1097/MPA.0000000000002165
M3 - Article
C2 - 37078947
AN - SCOPUS:85153414134
SN - 0885-3177
VL - 51
SP - 1211
EP - 1216
JO - Pancreas
JF - Pancreas
IS - 9
ER -
